PFIZER
Back to Cashflow Statement
|
PFIZER Last 5 Year Cash Flow from Financing Activities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹-205 Cr | ₹-235 Cr | ₹-346 Cr | ₹-181 Cr | ₹-1,571 Cr |
What is the latest Cash Flow from Financing Activities ratio of PFIZER ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2025 | ₹-205 Cr |
| Mar2024 | ₹-235 Cr |
| Mar2023 | ₹-346 Cr |
| Mar2022 | ₹-181 Cr |
| Mar2021 | ₹-1,571 Cr |
How is Cash Flow from Financing Activities of PFIZER Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-205 Cr | Negative | |
| Mar2024 | ₹-235 Cr | Negative | |
| Mar2023 | ₹-346 Cr | Negative | |
| Mar2022 | ₹-181 Cr | Negative | |
| Mar2021 | ₹-1,571 Cr | - | |
Compare Cash Flow from Financing Activities of peers of PFIZER
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| PFIZER | ₹22,640.0 Cr | 1.8% | 7.4% | 20.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹401,937.0 Cr | 1.2% | -7% | 2.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹165,359.0 Cr | 1.8% | 2.7% | 17% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹141,431.0 Cr | 0.5% | -4.8% | 32.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,114.0 Cr | 0.3% | -4.5% | 11.5% | Stock Analytics | |
| CIPLA | ₹100,028.0 Cr | 0.7% | -5.8% | -13.1% | Stock Analytics | |
PFIZER Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| PFIZER | 1.8% |
7.4% |
20.7% |
| SENSEX | 2.4% |
3.2% |
5.8% |
You may also like the below Video Courses